TY  - JOUR
AU  - Villanueva, Vicente
AU  - Carreño, Mar
AU  - Gil-Nagel, Antonio
AU  - Serrano-Castro, Pedro Jesús
AU  - Serratosa, José María
AU  - Toledo, Manuel
AU  - Álvarez-Barón, Elena
AU  - Gil, Alicia
AU  - Subías-Labazuy, Silvia
PY  - 2021
DO  - 10.1016/j.yebeh.2021.108222
UR  - https://hdl.handle.net/10668/24377
T2  - Epilepsy & behavior : E&B
AB  - Epilepsy is a serious neurological disease, ranking high in the top causes of disability. Approximately 40% of patients with epilepsy are pharmacoresistant after their seizures failed at least two antiseizure medications (ASMs). Adult patients...
LA  - en
KW  - Antiseizure medications
KW  - Drug-resistant epilepsy
KW  - Epilepsy
KW  - Focal-onset seizures
KW  - Multi-criteria decision analysis
KW  - Spain
KW  - Adult
KW  - Decision Support Techniques
KW  - Epilepsy
KW  - Humans
KW  - Pharmaceutical Preparations
KW  - Quality of Life
KW  - Seizures
KW  - Spain
TI  - Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through Multi-Criteria Decision Analysis (MCDA).
TY  - research article
VL  - 122
ER  -